TBX3 and breast carcinoma: More recently, TOPK has been shown to positively regulate the TBX3 in TGF‐β/Smad signalling pathway in breast cancer, thereby enhancing epithelial‐mesenchymal transition (EMT) and tumour cell invasion.36